-
Israeli Technology is Taking Regenerative Medicine into the FuturePublications -
Pearl Cohen Represents Orgenesis Inc. in Forming Strategic Partnership with Great Point Partners and Investment of up to $25 Million into MaSTherCell Global Inc.Publications -
Pearl Cohen Presents Biomedical & Life Science Innovation Poster AwardPublications -
Pearl Cohen Sponsors UCLA Biomedical and Life Science Innovation DayEvents -
Orgenesis Announces Listing on NASDAQ Capital MarketPublications -
Sol-Gel Announced the Pricing of its Initial Public Offering for $75.0 MillionPublications